JAFRON BIOMEDICAL revenue breakdown overview

JAFRON BIOMEDICAL revenue for the last year amounted to 1.92 B CNY, the most of which — 1.47 B CNY — came from its highest performing source at the moment, Disposable Blood Perfusion Device, the year earlier bringing 2.03 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought JAFRON BIOMEDICAL 1.87 B CNY, and the year before that — 2.43 B CNY.